CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
University of British Columbia
Vancouver, CanadáUniversity of British Columbia-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2022
-
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data
Multiple Sclerosis Journal, Vol. 28, Núm. 5, pp. 842-846
2021
-
Multiple sclerosis progression discussion tool usability and usefulness in clinical practice: Cross-sectional, web-based survey
Journal of Medical Internet Research, Vol. 23, Núm. 10
2020
-
Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
Frontiers in Pediatrics, Vol. 8
2019
-
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings
Frontiers in Neurology, Vol. 10